Publications by authors named "Veronica Candi"

Claim this Profile
C
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network.
Elisabetta Antonioli, Sofia Pilerci, Irene Attucci, Gabriele Buda, Alessandro Gozzetti, Veronica Candi

Front Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network).
Vincenzo Sammartano, Elisabetta Antonioli, Gabriele Buda, Sara Ciofini, Veronica Candi

J Pers Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study.
Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, Enrico Orciuolo, Francesco Ghio, Veronica Candi

Medicina (Kaunas)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia.
Vanessa Zurli, Giuliana Wimmer, Francesca Cattaneo, Veronica Candi, Emanuele Cencini

Blood· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia.
Alessandro Gozzetti, Veronica Candi, Corrado Zuanelli Brambilla, Giulia Papini, Alberto Fabbri

Anticancer Agents Med Chem· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second Generation Proteasome Inhibitors in Multiple Myeloma.
Alessandro Gozzetti, Giulia Papini, Veronica Candi, Corrado Zuanelli Brambilla, Santina Sirianni

Anticancer Agents Med Chem· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous (IV) bortezomib infusion after non-response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?
Alessandro Gozzetti, Veronica Candi, Corrado Zuanelli Brambilla, Giulia Papini, Monica Bocchia

Br J Haematol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Cytotoxic T Lymphocytes Form Dysfunctional Immune Synapses with B Cells Characterized by Non-Polarized Lytic Granule Release.
Anna Kabanova, Francesca Sanseviero, Veronica Candi, Alessandra Gamberucci, Alessandro Gozzetti

Cell Rep· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Cytotoxic T Lymphocytes Form Dysfunctional Immune Synapses with B Cells Characterized by Non-Polarized Lytic Granule Release.
Anna Kabanova, Francesca Sanseviero, Veronica Candi, Alessandra Gamberucci, Alessandro Gozzetti

Cell Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving treatments in multiple myeloma patients with renal failure.
Alessandro Gozzetti, Giulia Papini, Veronica Candi, Monica Bocchia

Rev Recent Clin Trials· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection.
Maria R Ambrosio, Giulia De Falco, Alessandro Gozzetti, Bruno J Rocca, Teresa Amato, Veronica Candi

Haematologica· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic advancements in multiple myeloma.
Alessandro Gozzetti, Veronica Candi, Giulia Papini, Monica Bocchia

Front Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia.
Alessandro Gozzetti, Veronica Candi, Alberto Fabbri, Luana Schiattone, Emanuele Cencini

Leuk Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system multiple myeloma: a different cytogenetic profile.
Alessandro Gozzetti, Adele Frasconi, Rosaria Crupi, Veronica Candi, Marzia Defina

Br J Haematol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis